Johnson & Johnson under pressure as FDA calls for pause on COVID vaccine By: TalkMarkets April 13, 2021 at 13:46 PM EDT Morgan Stanley believes J&J news could improve the 2022 outlook for mRNA vaccine makers. Read More >> Related Stocks: Johnson & Johnson Moderna Inc Pfizer